Molecular Imaging of Chemokine Receptor CXCR4

CXCR4 was found to be expressed by many different types of human cancers and its expression has been correlated with tumor aggressiveness, poor prognosis and resistance to chemotherapy. CXCR4 was also shown to contribute to metastatic seeding of organs that express its ligand CXCL12 and support the survival of these cells. These findings suggest that CXCR4 is a potentially attractive therapeutic target, and several antagonists and antibodies for this receptor were developed and are under clinical evaluation. Quantifying CXCR4 expression non-invasively might aid in prognostication as a mean for personalized therapy and post treatment monitoring. Multiple attempts were done over the recent years to develop imaging agents for CXCR4 using different technologies including PET, SPECT, fluorescent and bioluminescence, and will be reviewed in this paper.

• Publication year

  2013

• Venue

  Theranostics

• Publication date

  2013-01-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.7150/thno.4835PMID 23382787PMCID 3563082
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Positron Emission Tomography Imaging of Tumors Expressing the Human Chemokine Receptor CXCR4 in Mice with the Use of 64Cu-AMD3100

  2012cited by this paper
• Development of novel CXCR4-based therapeutics

  2012cited by this paper
• Development of a Unique Small Molecule Modulator of CXCR4

  2012cited by this paper
• Synthesis and in vitro evaluation of 68Ga-DOTA-4-FBn-TN14003, a novel tracer for the imaging of CXCR4 expression.

  2012cited by this paper
• Bioluminescence imaging: looking beyond the light.

  2012cited by this paper
• Improvement of CXCR4 tracer specificity for PET imaging.

  2012cited by this paper
• Peptide‐Functionalized Luminescent Iridium Complexes for Lifetime Imaging of CXCR4 Expression

  2011cited by this paper
• PET Imaging of CXCR4 Receptors in Cancer by a New Optimized Ligand

  2011cited by this paper
• Imaging CXCR4 Expression in Human Cancer Xenografts: Evaluation of Monocyclam 64Cu-AMD3465

  2011cited by this paper
• PET imaging of CXCR4 using copper-64 labeled peptide antagonist

  2011cited by this paper
• Scavenging of CXCL12 by CXCR7 Promotes Tumor Growth and Metastasis of CXCR4-positive Breast Cancer Cells

  2011cited by this paper
• Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7

  2011influential reference
• In Vivo Imaging of Ligand Receptor Binding with Gaussia Luciferase Complementation

  2011cited by this paper
• PET of CXCR4 Expression by a 68Ga-Labeled Highly Specific Targeted Contrast Agent

  2011cited by this paper
• Design, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4.

  2011cited by this paper
• Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression.

  2011cited by this paper
• Detection of CXCR4 receptors on cell surface using a fluorescent metal nanoshell.

  2011cited by this paper
• A sensitive phenotypic assay for the determination of human immunodeficiency virus type 1 tropism.

  2010cited by this paper
• CXCR4 and cancer

  2010cited by this paper
• Pre-clinical whole-body fluorescence imaging: Review of instruments, methods and applications.

  2010cited by this paper
• Antibody-protein A conjugated quantum dots for multiplexed imaging of surface receptors in living cells.

  2010cited by this paper
• PET of Tumor CXCR4 Expression with 4-18F-T140

  2010cited by this paper
• Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.

  2010cited by this paper
• Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.

  2009cited by this paper
• Immunoimaging of CXCR4 Expression in Brain Tumor Xenografts Using SPECT/CT

  2009cited by this paper
• 64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.

  2009cited by this paper
• Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.

  2009cited by this paper
• Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft‐tissue sarcoma

  2009cited by this paper
• CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.

  2009cited by this paper
• Fluorescent imaging of high‐grade bladder cancer using a specific antagonist for chemokine receptor CXCR4

  2009cited by this paper
• Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7.

  2009cited by this paper
• Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro.

  2008cited by this paper
• Synthesis and Application of Fluorescein‐ and Biotin‐Labeled Molecular Probes for the Chemokine Receptor CXCR4

  2008cited by this paper
• PET versus SPECT: strengths, limitations and challenges

  2008cited by this paper
• Imaging CXCR4 signaling with firefly luciferase complementation.

  2008cited by this paper
• Quantitation of CXCR4 Expression in Myocardial Infarction Using 99mTc-Labeled SDF-1α

  2008cited by this paper
• Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma.

  2007cited by this paper
• CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models.

  2007cited by this paper
• CXCR4 Inhibition Synergizes with Cytotoxic Chemotherapy in Gliomas

  2006cited by this paper
• Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.

  2006influential reference
• Clinical molecular imaging with positron emission tomography.

  2006cited by this paper
• Chemokine Receptors

  2006cited by this paper
• AIDS Res Hum Retroviruses

  2006cited by this paper
• Chemokines in tumor progression and metastasis

  2005cited by this paper
• Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat.

  2004cited by this paper
• The significance of cancer cell expression of the chemokine receptor CXCR4.

  2004cited by this paper
• Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis

  2004cited by this paper
• The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.

  2003cited by this paper
• Chemokines in cancer.

  2002cited by this paper
• SDF-1α/CXCR4: A Mechanism for Hepatic Oval Cell Activation and Bone Marrow Stem Cell Recruitment to the Injured Liver of Rats

  2002cited by this paper
• Prostate Cancer Metastasis to Bone Use of the Stromal Cell-derived Factor-1 / CXCR 4 Pathway in Updated Version

  2002cited by this paper
• Involvement of chemokine receptors in breast cancer metastasis

  2001cited by this paper
• Chemokine receptors.

  2001cited by this paper
• Chemokines in cancer

  2001cited by this paper
• CXCR4: chemokine receptor extraordinaire

  2000cited by this paper
• Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.

  1999cited by this paper
• New Reporter Cell Lines to Study Macrophage-Tropic HIV Envelope Protein-Mediated Cell-Cell Fusion

  1999cited by this paper
• Bioluminescent CXCL 12 fusion protein for cellular studies of CXCR 4 and CXCR 7

  year unknowncited by this paper

• Metabolizable van der Waals enhanced Raman scattering probes for CXCR4-targeted imaging guided cancer therapy in NIR-II window

  2026cites this paper
• Potential role of 68Ga- and 177Lu-cyclic pentapeptides for in-vivo targeting CXCR4 receptor expression in chemotherapy relapse MCL patient

  2026cites this paper
• Design and Evaluation of a 68Ga-Labeled Dimeric Cyclic Peptide as a Large-Volume Linker Strategy for Balancing Affinity and Retention in CXCR4-Targeted PET Imaging.

  2026cites this paper
• Gallium-68-labeled radiopharmaceuticals: a review.

  2025cites this paper
• Targeting CXCR4-expressing TAMs in muscle-invasive bladder cancer to enhance tumor control after immunotherapy

  2025cites this paper
• Development of a 177Lu-labeled radiopeptide for targeted CXCR4 positive tumor therapy.

  2025cites this paper
• Current Approaches of Nuclear Molecular Imaging in Breast Cancer

  2025cites this paper
• From macroscopic clearance to molecular eradication: paradigm shift and future perspectives in the detecting of residual lesions after transurethral resection of bladder tumors.

  2025cites this paper
• Recent Development of CXCR4-Targeted Nuclear Medicine Research in Adrenocortical Tumors.

  2025cites this paper
• Black Hole Quenchers for SERRS Imaging of CXCR4 Expression at Single‐Cell Level During Treatment

  2024cites this paper
• Role of the CXCR4-Gnαq-Plcβ signaling pathway in the pathogenesis of collagen-induced arthritis in rats

  2024cites this paper
• Development of a New Class of CXCR4-Targeting Radioligands Based on the Endogenous Antagonist EPI-X4 for Oncological Applications

  2023cites this paper
• Design of a New 99mTc-radiolabeled Cyclo-peptide as Promising Molecular Imaging Agent of CXCR4 Receptor: Molecular Docking, Synthesis, Radiolabeling, and Biological Evaluation.

  2023cites this paper
• Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging

  2023cites this paper
• Druggability of Targets for Diagnostic Radiopharmaceuticals.

  2023cites this paper
• Advances in the molecular imaging of primary aldosteronism

  2023cites this paper
• The Role of PET/CT in Breast Cancer

  2023cites this paper
• Imaging Aldosterone-Producing Adrenocortical Carcinoma With 68Ga-Pentixafor PET/CT.

  2022cites this paper
• Nuclear Medicine Application of Pentixafor/Pentixather Targeting CXCR4 for Imaging and Therapy in Related Disease.

  2022cites this paper
• Development and Evaluation of a Peptide Heterodimeric Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging

  2022cites this paper
• The Role of [68Ga]Ga-Pentixafor PET/CT or PET/MRI in Lymphoma: A Systematic Review

  2022cites this paper
• Clinical application of fluorescent probes

  2022cites this paper
• Molecular Imaging of Diabetes

  2021cites this paper
• In Vivo Targeting of CXCR4—New Horizons

  2021cites this paper
• ImmunoPET imaging of hematological malignancies: from preclinical promise to clinical reality.

  2021cites this paper
• Pre-clinical development of fluorescent tracers and translation towards clinical application

  2021cites this paper
• Post-Infarction Inflammatory Alterations

  2021cites this paper
• PET Imaging Radiotracers of Chemokine Receptors

  2021cites this paper
• CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway

  2020cites this paper
• ImmunoPET: Concept, Design, and Applications.

  2020cites this paper
• Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases

  2020cites this paper
• 64Cu PET Imaging of the CXCR4 Chemokine Receptor Using a Cross-Bridged Cyclam Bis-Tetraazamacrocyclic Antagonist

  2020cites this paper
• High-Contrast CXCR4-Targeted 18F-PET Imaging Using a Potent and Selective Antagonist.

  2020cites this paper
• At the Bench: Pre‐clinical evidence for multiple functions of CXCR4 in cancer

  2020cites this paper
• Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid N-Hydroxysuccinimide Ester (6-[18F]SFPy)

  2020cites this paper
• A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency

  2020cites this paper
• Radiolabelled CCK2R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation

  2020cites this paper
• Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours

  2020cites this paper
• Imaging of T-cells and their responses during anti-cancer immunotherapy

  2019cites this paper
• Recruiting potent membrane penetrability in tumor cell-targeted protein-only nanoparticles

  2019cites this paper
• A dual modality 99mTc/Re(i)-labelled T140 analogue for imaging of CXCR4 expression.

  2019cites this paper
• Radionuclide-Labeled Peptides for Imaging and Treatment of CXCR4- Overexpressing Malignant Tumors.

  2019cites this paper
• 64Cu-Labeled Ubiquitin for PET Imaging of CXCR4 Expression in Mouse Breast Tumor

  2019cites this paper
• Identification of biomarker microRNA-mRNA regulatory pairs for predicting the docetaxel resistance in prostate cancer

  2019cites this paper
• [68Ga]Ga/[177Lu]Lu-BL01, a Novel Theranostic Pair for Targeting C-X-C Chemokine Receptor 4.

  2019cites this paper
• C-terminal–modified LY2510924: a versatile scaffold for targeting C-X-C chemokine receptor type 4

  2019cites this paper
• Recent Advances in Nuclear Imaging of Receptor Expression to Guide Targeted Therapies in Breast Cancer

  2019cites this paper
• Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm.

  2019cites this paper
• Copper-64 PET imaging of the CXCR4 chemokine receptor using a cross-bridged cyclam bis-tetraazamacrocyclic antagonist

  2019cites this paper
• PET imaging of chemokine receptor CXCR4 in patients with primary and recurrent breast carcinoma

  2018cites this paper
• CXCR4-directed theranostics in oncology and inflammation

  2018cites this paper
• Self‐assembling toxin‐based nanoparticles as self‐delivered antitumoral drugs

  2018cites this paper
• Efficient Synthesis of Multifunctional Chelating Agents Based on Tetraazacycloalkanes

  2018cites this paper
• Radiotheranostics in Cancer Diagnosis and Management.

  2018cites this paper
• Radiolabelled peptides in medical imaging

  2018cites this paper
• Investigational PET tracers for high-grade gliomas.

  2018cites this paper
• Chemokine receptor - Directed imaging and therapy.

  2017cites this paper
• Straightforward synthesis of bis-tetraazacycloalkanes: towards new potential CXCR4 antagonists?

  2017cites this paper
• Development of Diagnostic and Therapeutic Radiopharmaceuticals targeting the Chemokine Receptor 4

  2017cites this paper
• Clinical Applications of Radiolabeled Peptides for PET.

  2017cites this paper
• A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors

  2017cites this paper
• Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using 64Cu-plerixafor PET

  2017cites this paper
• [177Lu]pentixather: Comprehensive Preclinical Characterization of a First CXCR4-directed Endoradiotherapeutic Agent

  2017cites this paper
• [64Cu]NOTA-pentixather enables high resolution PET imaging of CXCR4 expression in a preclinical lymphoma model

  2017cites this paper
• Molecular imaging to guide systemic cancer therapy: Illustrative examples of PET imaging cancer biomarkers.

  2017cites this paper
• Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases

  2017cites this paper
• Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.

  2016cites this paper
• A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts

  2016cites this paper
• The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity

  2016cites this paper
• Advanced Chelator Design for Metal Complexes in Imaging Applications: Radiopharmaceuticals, Protein Targeting, and Conjugation

  2016cites this paper
• Al[18F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression

  2016cites this paper
• Aspartate-Based CXCR4 Chemokine Receptor Binding of Cross-Bridged Tetraazamacrocyclic Copper(II) and Zinc(II) Complexes.

  2016cites this paper
• First Experience with Chemokine Receptor CXCR4–Targeted PET Imaging of Patients with Solid Cancers

  2016cites this paper
• Radiometallo-Labeled Peptides in Tumor Diagnosis and Targeted Radionuclide Therapy

  2016cites this paper
• First Experience on Chemokine Receptor CXCR4 Targeted Positron Emission Tomography (PET) Imaging in Patients with Solid Cancers

  2016cites this paper
• AMD3100: A Versatile Platform for CXCR4 Targeting (68)Ga-Based Radiopharmaceuticals.

  2016cites this paper
• Imaging CXCR4 Expression with 99mTc-Radiolabeled Small-Interference RNA in Experimental Human Breast Cancer Xenografts

  2016cites this paper
• The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.

  2015cites this paper
• TS‐Chemscore, a Target‐Specific Scoring Function, Significantly Improves the Performance of Scoring in Virtual Screening

  2015cites this paper
• Disclosing the CXCR4 Expression in Lymphoproliferative Diseases by Targeted Molecular Imaging

  2015cites this paper
• Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents.

  2015cites this paper
• Positron Emission Tomographic Imaging of CXCR4 in Cancer: Challenges and Promises

  2015cites this paper
• Prospective Study of 68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients

  2015cites this paper
• In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma

  2015cites this paper
• CXCR4-targeted near-infrared imaging allows detection of orthotopic and metastatic human osteosarcoma in a mouse model

  2015cites this paper
• New AMD3100 derivatives for CXCR4 chemokine receptor targeted molecular imaging studies: synthesis, anti-HIV-1 evaluation and binding affinities.

  2015cites this paper
• Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms

  2014cites this paper
• Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer

  2014cites this paper
• Regulation of metastatic action through CXCR4 and HPV16 E6/7 in cervical carcinogenesis

  2014cites this paper
• Molecular imaging agents for SPECT (and SPECT/CT)

  2014cites this paper
• Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics

  2013cites this paper
• CXCR4 Chemokine Receptor Overview: Biology, Pathology and Applications in Imaging and Therapy

  2013cites this paper